ERBB2 and breast cancer: An example of this is given by the efforts of Cailleux et al., which have analyzed the plasma samples of 13 TNBC, 11 HER2+, and 20 ER+ breast cancer patients at different time points: pre-NAC (baseline) and post-NAC treatments, before surgery and after surgery [38].